Indications
ZEPATIER is indicated for the treatment of chronic hepatitis C (CHC) in adult and paediatric patients 12 years of age and older who weigh at least 30 kg (see sections 4.2, 4.4 and 5.1). For hepatitis C virus (HCV) genotype-specific activity see sections 4.4 and 5.1.
Composition
- Active substance
- elbasvir, grazoprevir
- International name (INN)
- elbasvir;grazoprevir
Official product information
The European public assessment report holds the summary of product characteristics and the package leaflet in every EU language.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Medicine
- Zepatier
- Active substance
- elbasvir, grazoprevir
- ATC code
- J05AP54
- Therapeutic area
- Hepatitis C, Chronic